Lee M. Nadler

Lee M. Nadler

Medical Oncology, Dana Farber Cancer Institute

Affiliated withDana Farber Cancer InstituteBrigham and Womens Hospital

Research Area

Biography

Lee M. Nadler has not added Biography.
If you are Lee M. Nadler and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Publication title

Cited by 9

2011

Other Publications

Article
Year
A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254.

Leukemia & lymphoma| PubMed ID: 21275630

2011
2002
2002
2002
HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 12023395

2002
2003
From genomics to cancer vaccines: patient-tailored or universal vaccines?

Current opinion in molecular therapeutics| PubMed ID: 12596359

2002
MUC1-like tandem repeat proteins are broadly immunogenic in cancer patients.

Cancer immunity : a journal of the Academy of Cancer Immunology| PubMed ID: 12747745

2003
2003
2003
2003
2003
2004
Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 14871958

2004
2004
2004
pH-triggered microparticles for peptide vaccination.

Journal of immunology (Baltimore, Md. : 1950)| PubMed ID: 15294974

2004
2004
2005
2004
2004
2005
Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1.

International journal of cancer. Journal international du cancer| PubMed ID: 15688394

2005
2005
2005
2005
Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15958627

2005
2005
2005
2006
2006
2005
2006
2006
Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 16707591

2006
2006
Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 17363542

2007
Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation| PubMed ID: 17697968

2007
Lee Marshall Nadler, MD: a conversation with the editor.

Proceedings (Baylor University. Medical Center)| PubMed ID: 17948113

2007
2008
2008
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 18765557

2008
2008
Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 18829491

2008
Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 18927298

2008
2009
2010
2010
2011
2011
2011
Induction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cell.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 21705450

2011
2012
2012